Arcus Biosciences, Inc.

NYSE:RCUS

Pharmaceutical Preparations·HAYWARD, CA

CEO

Rosen Terry J

CFO

Goeltz Ii Robert C.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/25/26	→
10-Q	Q3 2025	9/30/25	10/28/25	→
10-Q	Q2 2025	6/30/25	8/6/25	→
10-Q	Q1 2025	3/31/25	5/6/25	→
10-K	FY 2024	12/31/24	2/25/25	→
10-Q	Q3 2024	9/30/24	11/6/24	→
↓

Earnings Releases (8-K)

29 shown

Filed	Period
2/25/26	Q1 FY2026	→
10/28/25	Q3 FY2025	→
8/6/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
2/25/25	Q1 FY2025	→
2/18/25	Q1 FY2025	→
↓

News (8-K)

51 shown

Filed	Type	Description
12/18/25	Agreement	Entry into a Material Definitive Agreement	→
12/12/25	Other	Other Events	→
11/3/25	Other	Other Events	→
10/14/25	Other	Other Events	→
10/6/25	Other	Other Events	→
6/12/25	Vote	Submission of Matters to a Vote of Security Holders	→
↓

Prospectuses & Registrations

29 shown

Filed	Form	Description
2/25/26	S-8	S-8	→
2/25/26	S-3ASR	S-3ASR	→
10/31/25	424B5	424B5	→
10/30/25	424B5	424B5	→
4/22/25	ARS	ARS	→
2/25/25	S-8	S-8	→
↓

Filing History(566 filings)

TypeDateAccessionPeriodSize

S-8

Feb 25, 2026

0001724521-26-000011S-8

—

273.0 KB

10-K

Feb 25, 2026

0001724521-26-00000910-K

Dec 31, 2025

11.2 MB

8-K

Feb 25, 2026

0001724521-26-0000078-K

Feb 25, 2026

313.7 KB

S-3ASR

Feb 25, 2026

0001193125-26-071862S-3ASR

—

1.2 MB

Jan 26, 2026

0002056093-26-000002FORM 4

Jan 23, 2026

6.9 KB

Jan 26, 2026

0001182473-26-000005FORM 4

Jan 23, 2026

6.9 KB

Jan 26, 2026

0001422996-26-000004FORM 4

Jan 23, 2026

7.6 KB

Jan 26, 2026

0001836662-26-000002FORM 4

Jan 23, 2026

6.9 KB

Jan 26, 2026

0001653881-26-000002FORM 4

Jan 23, 2026

6.9 KB

Jan 26, 2026

0001771961-26-000002FORM 4

Jan 23, 2026

6.9 KB

Jan 26, 2026

0001671311-26-000002FORM 4

Jan 23, 2026

7.0 KB

Jan 9, 2026

0001182473-26-000003FORM 4

Jan 8, 2026

4.6 KB

SCHEDULE 13G/A

Jan 8, 2026

0002012383-26-000038

—

10.7 KB

Jan 7, 2026

0001422996-26-000002FORM 4

Jan 5, 2026

9.4 KB

144

Jan 5, 2026

0001958244-26-000009

—

11.4 KB

Jan 2, 2026

0001610717-26-000002

Dec 31, 2025

4.3 KB

Jan 2, 2026

0001610717-26-000001

Dec 30, 2025

4.4 KB

144

Dec 31, 2025

0001628280-25-059249

—

6.5 KB

Dec 18, 2025

0001836662-25-000005FORM 4

Dec 16, 2025

7.6 KB

Dec 18, 2025

0002056093-25-000005FORM 4

Dec 16, 2025

7.8 KB

Dec 18, 2025

0001771961-25-000014FORM 4

Dec 16, 2025

9.5 KB

Dec 18, 2025

0001653881-25-000011FORM 4

Dec 16, 2025

7.4 KB

Dec 18, 2025

0001671311-25-000009FORM 4

Dec 16, 2025

7.5 KB

Dec 18, 2025

0001422996-25-000015FORM 4

Dec 16, 2025

8.1 KB

Dec 18, 2025

0001182473-25-000005FORM 4

Dec 16, 2025

7.7 KB

25 filings shown

Filed	Form	Description
4/22/25	DEFA14A	DEFA14A	→
4/22/25	DEF 14A	DEF 14A	→
4/23/24	DEFA14A	DEFA14A	→
4/23/24	DEF 14A	DEF 14A	→
4/21/23	DEFA14A	DEFA14A	→
4/21/23	DEF 14A	DEF 14A	→
↓

Arcus Biosciences, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(566 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
1/26/26	4	4	→
↓

Filed	Form	Description
1/8/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/5/26	144	144	→
12/31/25	144	144	→
12/18/25	144	144	→
12/15/25	144	144	→
12/15/25	144	144	→
↓